Related Experiment Video
Updated: May 4, 2026

A Rodent Model of The Ross Operation: Syngeneic Pulmonary Artery Graft Implantation in A Systemic Position
Published on: April 1, 2022
Aortic cusp extension for surgical correction of rheumatic aortic valve insufficiency in children
Afksendiyos Kalangos1, Patrick O Myers
1Division of Cardiovascular Surgery, Geneva University Hospital and Faculty of Medicine, Geneva, Switzerland.
Insights
Aortic valve repair using cusp extension in children with rheumatic disease offers a viable surgical option. This technique serves as a bridge to later valve replacement, particularly for those with small aortic annuli.
Area of Science:
- Cardiovascular Surgery
- Pediatric Cardiology
- Rheumatic Heart Disease
Background:
- Surgical management of aortic insufficiency in young patients is challenging due to the absence of an ideal valve substitute.
- Aortic valve repair offers potential benefits like reduced thromboembolism, endocarditis, and preserved growth, enhancing quality of life.
Purpose of the Study:
- To evaluate the long-term efficacy of aortic valve repair, specifically the cusp extension technique, in children with rheumatic aortic insufficiency.
- To assess the feasibility of cusp extension as a bridge to future aortic valve replacement in pediatric patients.
Main Methods:
- Retrospective analysis of 77 children undergoing aortic valve repair via cusp extension for rheumatic aortic insufficiency between 2003 and 2007.
- Mean follow-up of 12.8 years, analyzing reoperation rates, survival, and functional outcomes.
Main Results:
- One early death from ventricular failure and one late death from arrhythmia were recorded.
- 20.5% of patients required reoperation on the aortic valve, with a median time of 3.4 years post-repair.
- Freedom from reoperation at 1, 5, 10, 15, and 20 years was 96.2%, 88.5%, 81.7%, 79.7%, and 76.2%, respectively.
Conclusions:
- Aortic cusp extension is a technically demanding but suitable surgical approach for children with rheumatic aortic insufficiency and small aortic annuli.
- This repair technique serves as an effective bridge to eventual aortic valve replacement with larger prostheses, improving long-term outcomes.
Abstract:
Surgical management of aortic insufficiency in the young is problematic because of the lack of an ideal valve substitute. Potential advantages of aortic valve repair include low incidences of thromboembolism and endocarditis, avoiding conduit replacements, the maintenance of growth potential, and improved quality of life. Aortic valve repair is still far from fulfilling the three key factors that have allowed the phenomenal development of mitral valve repair (standardization, reproducibility, and stable long-term results); however, techniques of aortic valve repair have been refined, and subsets of patients amenable to repair have been identified. We have focused on the oldest technique of aortic valve repair, cusp extension, focusing on children with rheumatic aortic insufficiency. Among 77 children operated from 2003 to 2007, there was one early death from ventricular failure and one late death from sudden cardiac arrhythmia. During a mean follow-up of 12.8 ± 5.9 years, there were 16 (20.5%) reoperations on the aortic valve, at a median of 3.4 years (range, 2 months to 18.3 years) from repair. Freedom from aortic valve reoperation was 96.2% ± 2.2% at 1 year, 94.9% ± 2.5% at 2 years, 88.5% ± 3.6% at 5 years, 81.7% ± 4.4% at 10 years, 79.7% ± 4.8% at 15 years, and 76.2% ± 5.7% at 20 years. Although aortic cusp extension is technically more demanding, it remains particularly more suitable in the context of evolving rheumatic aortic insufficiency in children with a small aortic annulus as a bridge surgical approach to late aortic valve replacement with a larger valvular prosthesis.
Related Concept Videos
Aortic Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Aortic Regurgitation I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis I: Introduction
Mitral Regurgitation III: Medical Management

